Reema Zeineldin

Targeting the EGF Receptor for Ovarian Cancer Therapy

Laurie G. Hudson, M. Sharon Stack, M. Stack, 2009, Journal of oncology.

The Constitutive Activity of Epidermal Growth Factor Receptor vIII Leads to Activation and Differential Trafficking of Wild-type Epidermal Growth Factor Receptor and erbB2

Yan Ning, Laurie G Hudson, L. Hudson, 2010, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Role of polyethylene glycol integrity in specific receptor targeting of carbon nanotubes to cancer cells.

Laurie G Hudson, L. Hudson, M. Al-Haik, 2009, Nano letters.

Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation.

Yan Ning, Laurie G Hudson, M. Stack, 2005, Cancer research.

Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer.

R. Zeineldin, Reema Zeineldin, Paul S Kim, 2011, Gynecologic oncology.